Given the similar mutation rates of the BRCA1, BRCA2 and TP53 genes, Lee et al. [15] proposed that women who developed breast cancer before 30 years of age should undergo genetic testing for all three genes simultaneously. The gene discussed is BRCA2; the disease is breast cancer.